Feel Breathe, Restriction Device Ventilatory Nasal

NCT01608529 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2013-05-17

No results posted yet for this study

Summary

It has patented a restriction and filtering device ventilatory nasal flow FeelBreathe with the aim of increase nasal airflow resistance, therefore the objective was to examine the effects of FeelBreathe with lung ventilation and gas exchange during exercise.

Conditions

  • Mouth Breathing
  • Restrictive Breathing Pattern

Interventions

DEVICE

Feel Breathe, restriction device ventilatory nasal

The Feel Breathe (FB) consisted of a small adhesive strip that is placed across the bridge of the nose during exercise. The FB was place following procedures for placement as indicated by the manufacturer's directions, while the placebo nasal, was placed over the nostrils of the subject, without interfering nasal breathing; thus, nasal airflow resistance was not increase. Each subject was required to perform three identical submaximal exercises with intensity at 50% VT1-VT2 under different breathing conditions. The breathing conditions were: oronasal, nasal and FB breathing. All participants performed three trials of stable load (50% VT1-VT2) for 10 minutes in the three conditions mentioned above, setting the cadence at 70-75 rpm, and controlling the same in all three exercise conditions.

Sponsors & Collaborators

  • Consejo Superior de Deportes, Spain

    collaborator OTHER
  • European Regional Development Fund

    collaborator OTHER
  • University of Cadiz

    lead OTHER

Principal Investigators

  • Jose Lopez Chicharro, MD · Universidad Complutense de Madrid

  • Jorge dR Fernandez Santos, Phd Student · University of Cádiz (Spain)

  • Davinia Vicente Campos, Phd · Universidad Complutense de Madrid

  • Carmen Vaz Pardal, MD · Centro de Medicina del Deporte (Cádiz)

  • Jose L Costa Sepulveda, Phd Student · University of Cádiz (Spain)

  • Jose L Gonzalez Montesinos, Phd · University of Cádiz (Spain)

  • Jose Castro Piñero, Phd · University of Cádiz (Spain)

  • Julio Conde Caveda, Phd · University of Cádiz (Spain)

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-07-31
Completion
2011-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01608529 on ClinicalTrials.gov